Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000532937 | SCV000626070 | benign | Epidermodysplasia verruciformis | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001702670 | SCV005254460 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001702670 | SCV001931693 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727740 | SCV001968798 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925578 | SCV004751509 | benign | TMC6-related disorder | 2024-01-19 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |